Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

7.15
Delayed Data
As of Feb 08
 -0.29 / -3.90%
Today’s Change
5.91
Today|||52-Week Range
14.20
-44.66%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close7.44
Today’s open7.30
Day’s range7.07 - 7.52
Volume479,851
Average volume (3 months)540,244
Market cap$282.0M
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-513.74%
Earnings growth (this year)+76.05%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.23-4.02%
OMEDOncoMed Pharmaceutic...-0.10-1.07%
VTLVital Therapies Inc-0.26-2.84%
VSARVersartis Inc-0.62-6.62%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers